1. Home
  2. JF vs GNTA Comparison

JF vs GNTA Comparison

Compare JF & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JF

J and Friends Holdings Limited American Depositary Shares

N/A

Current Price

$1.02

Market Cap

18.5M

Sector

N/A

ML Signal

N/A

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$0.58

Market Cap

19.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JF
GNTA
Founded
2012
2014
Country
China
Italy
Employees
30
13
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.5M
19.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JF
GNTA
Price
$1.02
$0.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.9K
42.0K
Earning Date
04-24-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.89
$0.55
52 Week High
$1.12
$10.00

Technical Indicators

Market Signals
Indicator
JF
GNTA
Relative Strength Index (RSI) 52.69 40.11
Support Level $0.90 $0.61
Resistance Level $1.09 $0.76
Average True Range (ATR) 0.05 0.07
MACD -0.00 -0.00
Stochastic Oscillator 61.77 33.33

Price Performance

Historical Comparison
JF
GNTA

About JF J and Friends Holdings Limited American Depositary Shares

J and Friends Holdings Ltd providing merchant digitalization and commerce-enablement solutions to small and medium enterprises (SME). Its solutions feature critical functionality that SMEs need to engage with consumers, manage their operations, accept payments, and grow their business. Such solutions empower single- and multi-location retailers, restaurants, and other SMEs to compete successfully in an omni-channel market environment by engaging with consumers across online, mobile, and physical channels. The group conducts all of its current operations in Australia and generates revenues from continuing operations are derived from within Australia.

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: